Sruzam Labs

Gandhinagar, India Founded: 2016 • Age: 10 yrs
Manufactures pharmaceutical products and engages in strategic partnerships and acquisitions.

About Sruzam Labs

Sruzam Labs is a Healthcare company based in Gandhinagar (India) founded in 2016. It manufactures pharmaceutical products and engages in strategic partnerships and acquisitions. It operates on a B2B model in Healthcare and Consumer sectors. The company has 4 employees. Its Indian entity Sruzam Labs Private Limited reported revenue of β‚Ή6.17 Cr. Sruzam Labs offers products and services including Anti Allergic, Anti Cold, Anti Malarials, Anti-Infectives, and Appetizer Food Supplements. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Drugs and Consumer Goods. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Sruzam Labs, based in Gandhinagar, India, is a pharmaceutical company offering a wide range of products like anti-allergic and anti-malarial medications. They conduct research, manufacturing, and business development through strategic acquisitions and partnerships. The company focuses on quality, market leadership, and both domestic and international licensing to deliver health outcomes.

  • Headquarters Gandhinagar, India
  • Employees 4
  • Sectors
    Healthcare
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website sruzamlabs.com
  • Social LinkedIn Facebook
  • Legal Name Sruzam Labs Private Limited
  • Date of Incorporation 18 Mar, 2016
  • Jurisdiction Sampa, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹6.17 Cr

    FY 2025 · +7% YoY

  • Net Profit
    ₹6 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹1.50 Cr

    FY 2025 · 24% margin

  • Employee Count
    4

Products & Services of Sruzam Labs

Sruzam Labs offers a comprehensive portfolio of products and services, including Anti Allergic, Anti Cold, Anti Malarials, Anti-Infectives, and Appetizer Food Supplements.

Anti Allergic
Pharmaceuticals

Medications for treating allergies and related symptoms

Anti Cold
Pharmaceuticals

Remedies for cold and respiratory issues

Anti Malarials
Pharmaceuticals

Drugs to prevent and treat malaria infections

Anti-Infectives
Pharmaceuticals

Antibiotics for bacterial and viral infections

Appetizer Food Supplements
Nutritional Supplements

Supplements to enhance appetite and nutrition

Board of directors of Sruzam Labs Private Limited (Sruzam Labs)

Sruzam Labs Private Limited is the primary company behind Sruzam Labs. The board of Sruzam Labs Private Limited currently have 11 directors; the longest-serving is Himanshu Jitendrabhai Makani, appointed in 2016. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Himanshu Jitendrabhai Makani
DIN 07440704
Director18 Mar 201610 yrs 7 moSruzam Labs Private Limited
Satishkumar Ambalal Patel
DIN 07398909
Director18 Mar 201610 yrs 7 moSruzam Labs Private Limited
Rameshkumar Ambalal Pokar
DIN 07396794
Managing Director18 Mar 201610 yrs 7 moSruzam Labs Private Limited
Chandrakantbhai Tulshibhai Patel
DIN 07440582
Director18 Mar 201610 yrs 7 moSruzam Labs Private Limited
Jayantibhai Narayandas Patel
DIN 08606793
Director29 Nov 20196 yrs 11 moSruzam Labs Private Limited
Bhaveshkumar Karshanbhai Patel
DIN 08605892
Director29 Nov 20196 yrs 11 moSruzam Labs Private Limited
Kalpeshkumar Patel Ambalal
DIN 08605939
Director29 Nov 20196 yrs 11 moSruzam Labs Private Limited
Sudhirkumar Somalal Patel
DIN 08604962
Director29 Nov 20196 yrs 11 moSruzam Labs Private Limited
Satish Sureshbhai Patel
DIN 08608186
Director29 Nov 20196 yrs 11 moSruzam Labs Private Limited
Bharatbhai Dahyabhai Patel
DIN 08076670
Director29 Nov 20196 yrs 11 moSruzam Labs Private Limited
Patel Prashantkumar Jayantilal
DIN 11149118
Director14 Jun 20251 yr 4 moSruzam Labs Private Limited

Financials of Sruzam Labs

Figures of Sruzam Labs Private Limited, the primary company behind Sruzam Labs, for FY 2025. Revenue was ₹6.17 Cr (+7% year on year). Net profit was ₹6 Lakh (1% margin). EBITDA was ₹1.50 Cr (24% margin). Revenue has grown at a compounded annual rate of +88% over three years and +56% over five years.

  • ₹6.17 CrRevenue · FY 2025 · +7% YoY
  • ₹6 LakhNet profit · 1% margin
  • ₹1.50 CrEBITDA · 24% margin
  • ₹4.70 CrPaid-up capital
  • 4Employees (provident fund records)
  • +88%Revenue CAGR, 3 years
  • +56%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sruzam Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Sruzam Labs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Sruzam Labs

Sruzam Labs has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Sruzam Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sruzam Labs

Sruzam Labs was founded in 2016.

Sruzam Labs is headquartered in Gandhinagar, India. It is registered at Gandhinagar, Gujarat, India.

Sruzam Labs has 4 employees.

The primary company behind Sruzam Labs, Sruzam Labs Private Limited, reported revenue of β‚Ή6.17 Cr for FY 2025, up 7% year on year.

Sruzam Labs, based in Gandhinagar, India, is a pharmaceutical company offering a wide range of products like anti-allergic and anti-malarial medications. They conduct research, manufacturing, and business development through strategic acquisitions and partnerships. The company focuses on quality, market leadership, and both domestic and international licensing to deliver health outcomes.

Sruzam Labs's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Sruzam Labs offers Anti Allergic, Anti Cold, Anti Malarials, Anti-Infectives, and Appetizer Food Supplements.

Sruzam Labs operates through Sruzam Labs Private Limited.

The legal entities of Sruzam Labs currently have 11 directors, including Jayantibhai Narayandas Patel, Bhaveshkumar Karshanbhai Patel, Kalpeshkumar Patel Ambalal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available